Literature DB >> 10431747

Subclass profile of specific IgG antibodies in rats challenged during acute and chronic primary infection with Fasciola hepatica.

A Paz1, R Sánchez-Andrade, R Panadero, J L Suárez, P Díez-Baños, P Morrondo.   

Abstract

The influence of a previous infection (acute and chronic) on the kinetics of the immune humoral response in rats challenged with Fasciola hepatica was studied. Two infected groups were reinfected at different times--one, at 4 weeks after primary infection (w.a.p.i.); and the other, at 11 w.a.p.i. Signs of reinfection were observed in the two challenged groups as evidenced by an increment in glutamate dehydrogenase and gamma-glutamyl transpeptidase activity after secondary infection. IgG subclass (IgG1, IgG2a, IgG2b, IgG2c) responses to F. hepatica excretory/secretory products (FhESP) differed, depending on the time of challenge infection, but no difference was observed between the reinfected groups. A predominance of the IgG1 subclass was noted in the group challenged at 4 w.a.p.i., and IgG2b and IgG2c were prominent in the group reinfected at 11 w.a.p.i. These results indicate that the presence of juvenile or adult flukes in the liver at the time of challenge seems to influence the immune response to a secondary infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431747     DOI: 10.1007/s004360050629

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  2 in total

1.  Isolation, identification and expression of a Fasciola hepatica cDNA encoding a 2.9-kDa recombinant protein for the diagnosis of ovine fasciolosis.

Authors:  A Paz-Silva; G V Hillyer; R Sánchez-Andrade; J R Rodríguez-Medina; M Arias; P Morrondo; P Díez-Baños
Journal:  Parasitol Res       Date:  2004-12-18       Impact factor: 2.289

2.  Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.

Authors:  M Adela Valero; Ignacio Perez-Crespo; Carlos Chillón-Marinas; Messaoud Khoubbane; Carla Quesada; Marta Reguera-Gomez; Santiago Mas-Coma; Manuel Fresno; Núria Gironès
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.